About the Medical Oncology: Chemotherapy, targeted therapies, and combination regimens. Session
Medical oncology continues to evolve with advancements in chemotherapy, targeted therapies, and combination regimens. Case studies often focus on individualized treatment plans based on genetic and molecular tumor profiling, such as using EGFR inhibitors for non-small cell lung cancer. Combination regimens, like adding bevacizumab to chemotherapy, demonstrate enhanced efficacy for certain cancers. Additionally, the use of maintenance therapies prolongs progression-free survival in metastatic cases. These developments underscore the critical role of medical oncology in providing systemic treatments that complement surgical and radiation approaches, ensuring comprehensive cancer care tailored to each patient’s needs.
Topics Covered in Medical Oncology: Chemotherapy, targeted therapies, and combination regimens.
Cytotoxic Chemotherapy
Molecular Tumor Profiling
Kinase Inhibitor Therapy
Antiangiogenic Combinations
Maintenance Therapy
Treatment Sequencing
Related Scientific Sessions at CIOC 2027
Why Attend the Medical Oncology: Chemotherapy, targeted therapies, and combination regimens. Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Medical Oncology: Chemotherapy, targeted therapies, and combination regimens. work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Medical Oncology: Chemotherapy, targeted therapies, and combination regimens. research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Medical Oncology: Chemotherapy, targeted therapies, and combination regimens. track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Medical Oncology: Chemotherapy, targeted therapies, and combination regimens. Conference 2027 — FAQs
What is the Medical Oncology: Chemotherapy, targeted therapies, and combination regimens. track at CIOC 2027?
The Medical Oncology: Chemotherapy, targeted therapies, and combination regimens. track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Medical Oncology: Chemotherapy, targeted therapies, and combination regimens.. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Medical Oncology: Chemotherapy, targeted therapies, and combination regimens. sessions?
Cancer researchers and clinicians, educators and students with an interest in Medical Oncology: Chemotherapy, targeted therapies, and combination regimens. are all welcome — whether presenting or attending.
Can I present my research in the Medical Oncology: Chemotherapy, targeted therapies, and combination regimens. track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Medical Oncology: Chemotherapy, targeted therapies, and combination regimens. sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Medical Oncology: Chemotherapy, targeted therapies, and combination regimens. track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.